Your browser doesn't support javascript.
loading
Psilocybin prevents reinstatement of alcohol seeking by disrupting the reconsolidation of alcohol-related memories.
Benvenuti, F; Colombo, D; Soverchia, L; Cannella, N; Domi, E; Ciccocioppo, R.
Afiliación
  • Benvenuti F; School of Pharmacy, Center for Neuroscience, University of Camerino, Camerino, Italy.
  • Colombo D; School of Pharmacy, Center for Neuroscience, University of Camerino, Camerino, Italy.
  • Soverchia L; School of Pharmacy, Center for Neuroscience, University of Camerino, Camerino, Italy.
  • Cannella N; School of Pharmacy, Center for Neuroscience, University of Camerino, Camerino, Italy.
  • Domi E; School of Pharmacy, Center for Neuroscience, University of Camerino, Camerino, Italy.
  • Ciccocioppo R; School of Pharmacy, Center for Neuroscience, University of Camerino, Camerino, Italy. roberto.ciccocioppo@unicam.it.
Psychopharmacology (Berl) ; 240(7): 1521-1530, 2023 Jul.
Article en En | MEDLINE | ID: mdl-37266686
BACKGROUND: For most psychiatric conditions, including alcohol use disorder (AUD), FDA-approved pharmacological treatments are limited and their efficacy is restricted to only certain subgroups of patients. Scientific interest in the potential of psychedelic drugs has dramatically increased because of clinical preliminary evidence of efficacy in treating various psychiatric disorders. One of the most promising compounds belonging to this class of molecules is psilocybin. Here, to elucidate the therapeutic potential and treatment modalities of this drug, we investigated the effect of psilocybin on alcohol drinking and seeking in genetically selected Marchigian Sardinian alcohol-preferring (msP) rats, a well validated animal model of AUD characterized by excessive drinking and seeking. METHODS: Using male and female msP rats, we tested the effect of psilocybin on home cage voluntary alcohol consumption. We also tested the effect of the drug on the alcohol deprivation effect (ADE) model of relapse and on cue-induced reinstatement of alcohol seeking after a period of abstinence. Finally, we evaluated if psilocybin may disrupt the reconsolidation process of alcohol-related memory. RESULTS: Psilocybin did not reduce alcohol consumption, nor it prevented increased alcohol drinking after a period of forced abstinence and cue-induced reinstatement of alcohol-seeking. Noteworthy, in a memory retrieval-reconsolidation paradigm, psilocybin markedly attenuated resumption of alcohol seeking. CONCLUSIONS: Altogether these data suggest that, despite psilocybin does not affect alcohol drinking and relapse, it may be highly effective if used to block the reconsolidation process of alcohol-related memories. This opens to the possibility of using this psychedelic drug in clinical settings in which AUD patients undergo procedures to recall the memory of alcohol and are then treated with psilocybin during the memory reconsolidation phase.
Asunto(s)
Palabras clave

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Psilocibina / Alucinógenos Límite: Animals Idioma: En Revista: Psychopharmacology (Berl) Año: 2023 Tipo del documento: Article País de afiliación: Italia

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Psilocibina / Alucinógenos Límite: Animals Idioma: En Revista: Psychopharmacology (Berl) Año: 2023 Tipo del documento: Article País de afiliación: Italia